Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
J Am Med Womens Assoc. 1994 Jul-Aug;49(4):105-9.

The dilemma for women of color in clinical trials.

Author information

  • Department of Obstetrics and Gynecology, New York University Medical Center, New York City.

Abstract

Women in general and women of color in particular have been noticeably absent from clinical research, be it phase I pharmacokinetic drug trials or natural history observational studies. This paper examines several questions about the role of women of color in clinical research: Who participates in clinical trials and why? Do women of color face a particular dilemma in deciding to participate? A biologic construct for race and gender research issues is presented. Given the variations of pharmacokinetics and pharmacodynamics that may be race- or gender-related, certain obstacles must be addressed in order to facilitate responsible research. Those obstacles include the history of abuse of vulnerable populations in the name of clinical research, discrimination in medical care, and the lack of understanding of the combined impact of gender, race, ethnicity, and class on behavior and health.

PMID:
7930348
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk